Abstract
Dysregulation of RNA binding proteins (RBPs) is closely associated with tumor events. However, the function of RBPs in hepatocellular carcinoma (HCC) has not been fully elucidated. The RNA sequences and relevant clinical data of HCC were retrieved from the The Cancer Genome Atlas (TCGA) database to identify distinct RBPs. Subsequently, univariate and multivariate cox regression analysis was performed to evaluate the overall survival (OS)-associated RBPs. The expression levels of prognostic RBP genes and survival information were analyzed using a series of bioinformatics tool. A total of 365 samples with 1,542 RBPs were included in this study. One hundred and eighty-seven differently RBPs were screened, including 175 up-regulated and 12 down-regulated. The independent OS-associated RBPs of NHP2, UPF3B, and SMG5 were used to develop a prognostic model. Survival analysis showed that low-risk patients had a significantly longer OS and disease-free survival (DFS) when compared to high-risk patients (HR: 2.577, 95% CI: 1.793–3.704, P < 0.001 and HR: 1.599, 95% CI: 1.185–2.159, P = 0.001, respectively). The International Cancer Genome Consortium (ICGC) database was used to externally validate the model, and the OS of low-risk patients were found to be longer than that of high-risk patients (P < 0.001). The Nomograms of OS and DFS were plotted to help in clinical decision making. These results showed that the model was effective and may help in prognostic stratification of HCC patients. The prognostic prediction model based on RBPs provides new insights for HCC diagnosis and personalized treatment.
Highlights
Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-associated mortalities, and the sixth leading among cancer incidences globally [1]
These results showed that high expression of NHP2, UPF3B, and SMG5 is associated with poor prognosis in hepatocellular carcinoma (HCC) patients
RNA binding proteins (RBPs) play a central role in the regulation of gene expression, and their dysregulation has been linked to several human diseases as well as to the occurrence of numerous malignant tumors [20, 21]
Summary
Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-associated mortalities, and the sixth leading among cancer incidences globally [1]. RNA binding proteins (RBPs) are pleiotropic proteins that regulate gene expression at the post-transcriptional level by interacting with target RNA modules [6, 7]. RBPs are generally recognized as proteins that bind to a variety of RNAs, such as ribosomal RNAs (rRNAs), microRNAs (miRNAs), small nuclear RNAs (snRNAs), non-coding RNAs (ncRNAs), messenger RNAs (mRNAs), small nucleolar RNAs (snoRNAs), and transfer RNAs (tRNAs). Previous studies have shown that RBPs are involved in regulating RNA stability, alternative splicing, modification, location, and translation [8]. RBPs directly bind to chromatin to regulate gene expression [9]. Expression of RBP genes adversely affects alternative splicing, polyadenylation apoptosis, among other physiologic processes of the cell [10, 11]. RBPs have been implicated in processes that promote tumorigenesis and development [10, 12, 13]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
